Attention Bias Modification Versus Attention Control in Treatment of Social Anxiety
1 other identifier
interventional
50
1 country
1
Brief Summary
The purpose of this study is to compare the clinical efficacy of treatment using gaze contingent music reward therapy (GC-MRT) with attention control treatment based on a similar paradigm, for social anxiety disorder (SAD)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2021
CompletedFirst Submitted
Initial submission to the registry
August 18, 2021
CompletedFirst Posted
Study publicly available on registry
August 24, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2022
CompletedJanuary 4, 2023
January 1, 2023
8 months
August 18, 2021
January 1, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from baseline - the Liebowitz Social Anxiety Scale (LSAS) - Diagnostic Interview scores
The Liebowitz Social Anxiety Scale (LSAS) is a 24-item scale, each item corresponding to a situation selected on the basis of clinical experience. Each item is rated on a severity scale ranging from 0 to 3 with regard to the passing week, measuring separately two components of social anxiety, specifically, fear/anxiety and avoidance of social interaction and performance situations. The minimum and maximum values of the LSAS total score are 0 and 144, respectively, with higher scores mean worse outcome. Although the assessor may request and ask for further detail and adjust the rating based on clinical experience, this option is not often exercised, and inter-rater agreement is not considered to be a relevant concern.
at baseline, one week after end of intervention
Secondary Outcomes (2)
Change from baseline - the Social Phobia Inventory scores
at baseline, one week after end of intervention
Clinical Global Impression
at baseline, one week after end of intervention
Other Outcomes (4)
Change from baseline -Attention Control Scale- ACS
at baseline, one week after end of intervention
Change from baseline - Patient Health Questionnaire- PHQ9
at baseline, one week after end of intervention
Viewing patterns on disgusted and neutral faces, and round/sharp shapes< representing attention bias.
at baseline, one week after end of intervention
- +1 more other outcomes
Study Arms (2)
GCMRT
EXPERIMENTALAttention bias modification: participants will receive gaze-contingent feedback according to their viewing patterns on disgusted and neutral faces
attention control
EXPERIMENTALAttention control modification: participants will receive gaze-contingent feedback according to their viewing patterns on rounded and sharp geometric shapes
Interventions
Feedback according to participants' viewing patterns, in order to modify their attention bias to threat
Feedback according to participants' viewing patterns, in order to strengthen their attention control
Eligibility Criteria
You may qualify if:
- A signed consent form
- Men and women between the ages of 18 and 65.
- Meeting a current diagnosis of Social Anxiety Disorder (SP) according to the DSM-IV.
- SP as the primary diagnosis: In cases of co-morbidity, SP will be deemed as the most distressing and clinically significant condition among the co-morbid disorders.
- No current pharmaco-therapy.
You may not qualify if:
- A diagnosis of psychotic or bipolar disorders.
- A diagnosis of a neurological disorder (i.e., epilepsy, brain injury).
- Drug or alcohol abuse.
- Any current pharmacological treatment.
- Any current psychotherapeutic treatment.
- Change in treatment during the study.
- Poor judgment capacity (i.e., children under 18 and special populations).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tel Aviv University
Tel Aviv, 55555, Israel
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yair Bar-Haim, PhD
Tel Aviv University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- particiapants, investigators and outcome assessors are blind to allocation
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
August 18, 2021
First Posted
August 24, 2021
Study Start
May 1, 2021
Primary Completion
January 1, 2022
Study Completion
April 1, 2022
Last Updated
January 4, 2023
Record last verified: 2023-01
Data Sharing
- IPD Sharing
- Will not share